Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology
-10%
portes grátis
Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology
Feigin, Valery L.; Brayne, Carol; Logroscino, Giancarlo; Launer, Lenore J.
Oxford University Press
11/2020
512
Dura
Inglês
9780198749493
15 a 20 dias
1672
Descrição não disponível.
1: German E. Berrios and Ivana S. Markova: A historical perspective on neurological and neuropsychiatric definitions
2: V.R. Varma, Y. F. Chuang, and M. Thambisetty: Neuroimaging and fluid biomarkers of Alzheimer s disease: implications for definition, diagnosis and treatment
3: Yoav Ben-Shlomo: Life course, exposure, and ageing populations
4: Kenneth M. Langa, Eileen Crimmins, and Mark D. Hayward: Examining trends in dementia incidence and prevalence using an age-period-cohort framework
5: Derrick A. Bennett: Overview of common designs, measures of effect, and biases in neuro-epidemiological studies
6: Maelenn Guerchet, Rosie Mayston, and A. Matthew Prina: Conducting research in low and middle income settings.
7: Edo Richard: Trial designs including observational to interventional
8: Chengxuan Qiu, Davide Liborio Vetrano, and Laura Fratiglioni: Cardiometabolic morbidities and dementia
9: Ratnavalli Ellajosyula: Early onset Alzheimer s disease
10: Juliana R. Dutra: Huntington s Disease
11: Valentina Gallo, Tanya P. Garcia, and Karen Marder: Idiopathic Parkinson s disease and classification of Parkinsonisms
12: Rodolfo Savica and Pierpaolo Turcano: Dementia and Parkinson s disease
13: Giancarlo Logroscino and Adriano Chio: FTD and ALS
14: James B. Rowe and Ian T.S. Coyle-Gilchrist: Rare Neurodegenerative Parkinsonism (PSP, MSA, CBD)
15: Keir X. X. Yong, S. J. Crutch, and J. M. Schott: Posterior Cortical Atrophy
16: Elan D. Louis: Epidemiology of essential tremor
17: Amy R. Borenstein: Detecting dementia early in populations
18: Maria M. Corrada and Claudia H. Kawas: The oldest-old and dementia at the end of life
19: Rita V. Krishnamurthy and Valery L. Feigin: Global stroke burden and prevention strategies- findings from GBD 2015
20: Bo Norrving, MD, PhD: Stroke and TIA
21: Fergus Doubal, Anna Poggesi, Leonardo Pantoni, and Joanna Wardlaw: Small vessel disease
22: Julio R. Vieira and Richard B. Lipton: Migraine: Descriptive epidemiology and related neurobiology
23: Stina Saunders, Graciela Muniz-Terrera , Tom C. Russ, Craig W. Ritchie, and Karen Ritchie: The clinical spectrum of neurodegenerative disease: moving beyond Mild Cognitive Impairment
24: Sergio Starkstein, Bradleigh Hayhow, and Pierre Wibawa: The epidemiology of apathy in neurological disorders
25: Rianne van der Linde and Tom Dening: Behavioural and Psychological Symptoms of Dementia
26: Daniel Davis, Sarah Richardson, and Esteban Sepulveda: Delirium
27: Mirjam I. Geerlings: Methods and approaches to examining the interface of late-life depression and dementia
28: Assen Jablensky, H. E. Jongsma HE, James B. Kirkbride, and Peter B. Jones: Epidemiology of schizophrenia and related disorders
29: Elisabeth Gulowsen Celius: Multiple sclerosis: Descriptive epidemiology and related neurobiology
30: Anne Taraldsen Heldal and Nils Erik Gilhus: Myasthenia gravis
31: Ettore Beghi, Giorgia Giussani, and Torbjorn Tomson: Epilepsy
32: Ettore Beghi, Giorgia Giussani, and Marco Poloni: Neuropathies: Descriptive epidemiology and related neurobiology
33: Paul J. Foster, Anthony Khawaja, Lisanne J. Balk, Zaynah Muthy, and Axel Petzold: Sensory loss Vision
34: Adele M. Goman and Frank R. Lin: Sensory loss - Hearing
35: Patrick J. M. Urwin and Anna M. Molesworth: The Neuroepidemiology of Human Prion Disease
36: Charles R. Newton: Epidemiology of bacterial and parasitic infections of the central nervous system
37: Ines Yoro-Zohoun, Jaime Luna, Salmane Amidou, and Pierre-Marie Preux: Infection: other than bacterial, including HIV
38: Alice Theadom and Kelly M. Jones: Traumatic brain and spinal cord injury
39: Joachim Schuez and Maria Feychting: Electromagnetic fields
40: Susan Peters, Anne E. Visser, Marc Weisskopf, Marianthi-Anna Kioumourtzoglou, and Roel Vermeulen: Metals and neurodegeneration
41: Thomas Truelsen, Catherine Johnson, Mohsen Naghavi, Theo Vos, Valery L. Feigin, and Gregory Roth: Estimating the global burden of stroke: methods and challenges
42: Carol Brayne: What is the role of trials and other well designed studies in the understanding of neurological and neuropsychiatric conditions
43: Ann I. Scher, David W. Niebuhr, and Darrell Singer: Research and methodologic opportunities and challenges conducting research among U.S military personnel
44: Adesola Ogunniyi: Global evidence generation
45: Giancarlo Logroscino, Carol Brayne, and Rosanna Tortelli: The role of prevention in common neurological disorders
2: V.R. Varma, Y. F. Chuang, and M. Thambisetty: Neuroimaging and fluid biomarkers of Alzheimer s disease: implications for definition, diagnosis and treatment
3: Yoav Ben-Shlomo: Life course, exposure, and ageing populations
4: Kenneth M. Langa, Eileen Crimmins, and Mark D. Hayward: Examining trends in dementia incidence and prevalence using an age-period-cohort framework
5: Derrick A. Bennett: Overview of common designs, measures of effect, and biases in neuro-epidemiological studies
6: Maelenn Guerchet, Rosie Mayston, and A. Matthew Prina: Conducting research in low and middle income settings.
7: Edo Richard: Trial designs including observational to interventional
8: Chengxuan Qiu, Davide Liborio Vetrano, and Laura Fratiglioni: Cardiometabolic morbidities and dementia
9: Ratnavalli Ellajosyula: Early onset Alzheimer s disease
10: Juliana R. Dutra: Huntington s Disease
11: Valentina Gallo, Tanya P. Garcia, and Karen Marder: Idiopathic Parkinson s disease and classification of Parkinsonisms
12: Rodolfo Savica and Pierpaolo Turcano: Dementia and Parkinson s disease
13: Giancarlo Logroscino and Adriano Chio: FTD and ALS
14: James B. Rowe and Ian T.S. Coyle-Gilchrist: Rare Neurodegenerative Parkinsonism (PSP, MSA, CBD)
15: Keir X. X. Yong, S. J. Crutch, and J. M. Schott: Posterior Cortical Atrophy
16: Elan D. Louis: Epidemiology of essential tremor
17: Amy R. Borenstein: Detecting dementia early in populations
18: Maria M. Corrada and Claudia H. Kawas: The oldest-old and dementia at the end of life
19: Rita V. Krishnamurthy and Valery L. Feigin: Global stroke burden and prevention strategies- findings from GBD 2015
20: Bo Norrving, MD, PhD: Stroke and TIA
21: Fergus Doubal, Anna Poggesi, Leonardo Pantoni, and Joanna Wardlaw: Small vessel disease
22: Julio R. Vieira and Richard B. Lipton: Migraine: Descriptive epidemiology and related neurobiology
23: Stina Saunders, Graciela Muniz-Terrera , Tom C. Russ, Craig W. Ritchie, and Karen Ritchie: The clinical spectrum of neurodegenerative disease: moving beyond Mild Cognitive Impairment
24: Sergio Starkstein, Bradleigh Hayhow, and Pierre Wibawa: The epidemiology of apathy in neurological disorders
25: Rianne van der Linde and Tom Dening: Behavioural and Psychological Symptoms of Dementia
26: Daniel Davis, Sarah Richardson, and Esteban Sepulveda: Delirium
27: Mirjam I. Geerlings: Methods and approaches to examining the interface of late-life depression and dementia
28: Assen Jablensky, H. E. Jongsma HE, James B. Kirkbride, and Peter B. Jones: Epidemiology of schizophrenia and related disorders
29: Elisabeth Gulowsen Celius: Multiple sclerosis: Descriptive epidemiology and related neurobiology
30: Anne Taraldsen Heldal and Nils Erik Gilhus: Myasthenia gravis
31: Ettore Beghi, Giorgia Giussani, and Torbjorn Tomson: Epilepsy
32: Ettore Beghi, Giorgia Giussani, and Marco Poloni: Neuropathies: Descriptive epidemiology and related neurobiology
33: Paul J. Foster, Anthony Khawaja, Lisanne J. Balk, Zaynah Muthy, and Axel Petzold: Sensory loss Vision
34: Adele M. Goman and Frank R. Lin: Sensory loss - Hearing
35: Patrick J. M. Urwin and Anna M. Molesworth: The Neuroepidemiology of Human Prion Disease
36: Charles R. Newton: Epidemiology of bacterial and parasitic infections of the central nervous system
37: Ines Yoro-Zohoun, Jaime Luna, Salmane Amidou, and Pierre-Marie Preux: Infection: other than bacterial, including HIV
38: Alice Theadom and Kelly M. Jones: Traumatic brain and spinal cord injury
39: Joachim Schuez and Maria Feychting: Electromagnetic fields
40: Susan Peters, Anne E. Visser, Marc Weisskopf, Marianthi-Anna Kioumourtzoglou, and Roel Vermeulen: Metals and neurodegeneration
41: Thomas Truelsen, Catherine Johnson, Mohsen Naghavi, Theo Vos, Valery L. Feigin, and Gregory Roth: Estimating the global burden of stroke: methods and challenges
42: Carol Brayne: What is the role of trials and other well designed studies in the understanding of neurological and neuropsychiatric conditions
43: Ann I. Scher, David W. Niebuhr, and Darrell Singer: Research and methodologic opportunities and challenges conducting research among U.S military personnel
44: Adesola Ogunniyi: Global evidence generation
45: Giancarlo Logroscino, Carol Brayne, and Rosanna Tortelli: The role of prevention in common neurological disorders
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
1: German E. Berrios and Ivana S. Markova: A historical perspective on neurological and neuropsychiatric definitions
2: V.R. Varma, Y. F. Chuang, and M. Thambisetty: Neuroimaging and fluid biomarkers of Alzheimer s disease: implications for definition, diagnosis and treatment
3: Yoav Ben-Shlomo: Life course, exposure, and ageing populations
4: Kenneth M. Langa, Eileen Crimmins, and Mark D. Hayward: Examining trends in dementia incidence and prevalence using an age-period-cohort framework
5: Derrick A. Bennett: Overview of common designs, measures of effect, and biases in neuro-epidemiological studies
6: Maelenn Guerchet, Rosie Mayston, and A. Matthew Prina: Conducting research in low and middle income settings.
7: Edo Richard: Trial designs including observational to interventional
8: Chengxuan Qiu, Davide Liborio Vetrano, and Laura Fratiglioni: Cardiometabolic morbidities and dementia
9: Ratnavalli Ellajosyula: Early onset Alzheimer s disease
10: Juliana R. Dutra: Huntington s Disease
11: Valentina Gallo, Tanya P. Garcia, and Karen Marder: Idiopathic Parkinson s disease and classification of Parkinsonisms
12: Rodolfo Savica and Pierpaolo Turcano: Dementia and Parkinson s disease
13: Giancarlo Logroscino and Adriano Chio: FTD and ALS
14: James B. Rowe and Ian T.S. Coyle-Gilchrist: Rare Neurodegenerative Parkinsonism (PSP, MSA, CBD)
15: Keir X. X. Yong, S. J. Crutch, and J. M. Schott: Posterior Cortical Atrophy
16: Elan D. Louis: Epidemiology of essential tremor
17: Amy R. Borenstein: Detecting dementia early in populations
18: Maria M. Corrada and Claudia H. Kawas: The oldest-old and dementia at the end of life
19: Rita V. Krishnamurthy and Valery L. Feigin: Global stroke burden and prevention strategies- findings from GBD 2015
20: Bo Norrving, MD, PhD: Stroke and TIA
21: Fergus Doubal, Anna Poggesi, Leonardo Pantoni, and Joanna Wardlaw: Small vessel disease
22: Julio R. Vieira and Richard B. Lipton: Migraine: Descriptive epidemiology and related neurobiology
23: Stina Saunders, Graciela Muniz-Terrera , Tom C. Russ, Craig W. Ritchie, and Karen Ritchie: The clinical spectrum of neurodegenerative disease: moving beyond Mild Cognitive Impairment
24: Sergio Starkstein, Bradleigh Hayhow, and Pierre Wibawa: The epidemiology of apathy in neurological disorders
25: Rianne van der Linde and Tom Dening: Behavioural and Psychological Symptoms of Dementia
26: Daniel Davis, Sarah Richardson, and Esteban Sepulveda: Delirium
27: Mirjam I. Geerlings: Methods and approaches to examining the interface of late-life depression and dementia
28: Assen Jablensky, H. E. Jongsma HE, James B. Kirkbride, and Peter B. Jones: Epidemiology of schizophrenia and related disorders
29: Elisabeth Gulowsen Celius: Multiple sclerosis: Descriptive epidemiology and related neurobiology
30: Anne Taraldsen Heldal and Nils Erik Gilhus: Myasthenia gravis
31: Ettore Beghi, Giorgia Giussani, and Torbjorn Tomson: Epilepsy
32: Ettore Beghi, Giorgia Giussani, and Marco Poloni: Neuropathies: Descriptive epidemiology and related neurobiology
33: Paul J. Foster, Anthony Khawaja, Lisanne J. Balk, Zaynah Muthy, and Axel Petzold: Sensory loss Vision
34: Adele M. Goman and Frank R. Lin: Sensory loss - Hearing
35: Patrick J. M. Urwin and Anna M. Molesworth: The Neuroepidemiology of Human Prion Disease
36: Charles R. Newton: Epidemiology of bacterial and parasitic infections of the central nervous system
37: Ines Yoro-Zohoun, Jaime Luna, Salmane Amidou, and Pierre-Marie Preux: Infection: other than bacterial, including HIV
38: Alice Theadom and Kelly M. Jones: Traumatic brain and spinal cord injury
39: Joachim Schuez and Maria Feychting: Electromagnetic fields
40: Susan Peters, Anne E. Visser, Marc Weisskopf, Marianthi-Anna Kioumourtzoglou, and Roel Vermeulen: Metals and neurodegeneration
41: Thomas Truelsen, Catherine Johnson, Mohsen Naghavi, Theo Vos, Valery L. Feigin, and Gregory Roth: Estimating the global burden of stroke: methods and challenges
42: Carol Brayne: What is the role of trials and other well designed studies in the understanding of neurological and neuropsychiatric conditions
43: Ann I. Scher, David W. Niebuhr, and Darrell Singer: Research and methodologic opportunities and challenges conducting research among U.S military personnel
44: Adesola Ogunniyi: Global evidence generation
45: Giancarlo Logroscino, Carol Brayne, and Rosanna Tortelli: The role of prevention in common neurological disorders
2: V.R. Varma, Y. F. Chuang, and M. Thambisetty: Neuroimaging and fluid biomarkers of Alzheimer s disease: implications for definition, diagnosis and treatment
3: Yoav Ben-Shlomo: Life course, exposure, and ageing populations
4: Kenneth M. Langa, Eileen Crimmins, and Mark D. Hayward: Examining trends in dementia incidence and prevalence using an age-period-cohort framework
5: Derrick A. Bennett: Overview of common designs, measures of effect, and biases in neuro-epidemiological studies
6: Maelenn Guerchet, Rosie Mayston, and A. Matthew Prina: Conducting research in low and middle income settings.
7: Edo Richard: Trial designs including observational to interventional
8: Chengxuan Qiu, Davide Liborio Vetrano, and Laura Fratiglioni: Cardiometabolic morbidities and dementia
9: Ratnavalli Ellajosyula: Early onset Alzheimer s disease
10: Juliana R. Dutra: Huntington s Disease
11: Valentina Gallo, Tanya P. Garcia, and Karen Marder: Idiopathic Parkinson s disease and classification of Parkinsonisms
12: Rodolfo Savica and Pierpaolo Turcano: Dementia and Parkinson s disease
13: Giancarlo Logroscino and Adriano Chio: FTD and ALS
14: James B. Rowe and Ian T.S. Coyle-Gilchrist: Rare Neurodegenerative Parkinsonism (PSP, MSA, CBD)
15: Keir X. X. Yong, S. J. Crutch, and J. M. Schott: Posterior Cortical Atrophy
16: Elan D. Louis: Epidemiology of essential tremor
17: Amy R. Borenstein: Detecting dementia early in populations
18: Maria M. Corrada and Claudia H. Kawas: The oldest-old and dementia at the end of life
19: Rita V. Krishnamurthy and Valery L. Feigin: Global stroke burden and prevention strategies- findings from GBD 2015
20: Bo Norrving, MD, PhD: Stroke and TIA
21: Fergus Doubal, Anna Poggesi, Leonardo Pantoni, and Joanna Wardlaw: Small vessel disease
22: Julio R. Vieira and Richard B. Lipton: Migraine: Descriptive epidemiology and related neurobiology
23: Stina Saunders, Graciela Muniz-Terrera , Tom C. Russ, Craig W. Ritchie, and Karen Ritchie: The clinical spectrum of neurodegenerative disease: moving beyond Mild Cognitive Impairment
24: Sergio Starkstein, Bradleigh Hayhow, and Pierre Wibawa: The epidemiology of apathy in neurological disorders
25: Rianne van der Linde and Tom Dening: Behavioural and Psychological Symptoms of Dementia
26: Daniel Davis, Sarah Richardson, and Esteban Sepulveda: Delirium
27: Mirjam I. Geerlings: Methods and approaches to examining the interface of late-life depression and dementia
28: Assen Jablensky, H. E. Jongsma HE, James B. Kirkbride, and Peter B. Jones: Epidemiology of schizophrenia and related disorders
29: Elisabeth Gulowsen Celius: Multiple sclerosis: Descriptive epidemiology and related neurobiology
30: Anne Taraldsen Heldal and Nils Erik Gilhus: Myasthenia gravis
31: Ettore Beghi, Giorgia Giussani, and Torbjorn Tomson: Epilepsy
32: Ettore Beghi, Giorgia Giussani, and Marco Poloni: Neuropathies: Descriptive epidemiology and related neurobiology
33: Paul J. Foster, Anthony Khawaja, Lisanne J. Balk, Zaynah Muthy, and Axel Petzold: Sensory loss Vision
34: Adele M. Goman and Frank R. Lin: Sensory loss - Hearing
35: Patrick J. M. Urwin and Anna M. Molesworth: The Neuroepidemiology of Human Prion Disease
36: Charles R. Newton: Epidemiology of bacterial and parasitic infections of the central nervous system
37: Ines Yoro-Zohoun, Jaime Luna, Salmane Amidou, and Pierre-Marie Preux: Infection: other than bacterial, including HIV
38: Alice Theadom and Kelly M. Jones: Traumatic brain and spinal cord injury
39: Joachim Schuez and Maria Feychting: Electromagnetic fields
40: Susan Peters, Anne E. Visser, Marc Weisskopf, Marianthi-Anna Kioumourtzoglou, and Roel Vermeulen: Metals and neurodegeneration
41: Thomas Truelsen, Catherine Johnson, Mohsen Naghavi, Theo Vos, Valery L. Feigin, and Gregory Roth: Estimating the global burden of stroke: methods and challenges
42: Carol Brayne: What is the role of trials and other well designed studies in the understanding of neurological and neuropsychiatric conditions
43: Ann I. Scher, David W. Niebuhr, and Darrell Singer: Research and methodologic opportunities and challenges conducting research among U.S military personnel
44: Adesola Ogunniyi: Global evidence generation
45: Giancarlo Logroscino, Carol Brayne, and Rosanna Tortelli: The role of prevention in common neurological disorders
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
